These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 21586460)

  • 1. NICE on ovarian cancer. Recommendations for detection in primary care are flawed.
    Olaitan A
    BMJ; 2011 May; 342():d3022. PubMed ID: 21586460
    [No Abstract]   [Full Text] [Related]  

  • 2. NICE on ovarian cancer. Please include GPs in developing guidelines.
    Cave JA
    BMJ; 2011 May; 342():d3023. PubMed ID: 21586461
    [No Abstract]   [Full Text] [Related]  

  • 3. Recognition and initial management of ovarian cancer: summary of NICE guidance.
    Redman C; Duffy S; Bromham N; Francis K;
    BMJ; 2011 Apr; 342():d2073. PubMed ID: 21511784
    [No Abstract]   [Full Text] [Related]  

  • 4. Women with symptoms of ovarian cancer should have a CA125 test, says NICE.
    Gulland A
    BMJ; 2011 Apr; 342():d2695. PubMed ID: 21525103
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathways to the diagnosis of ovarian cancer in the UK: a cohort study in primary care.
    Parkin D; Cruickshank M
    BJOG; 2010 Jul; 117(8):1033; author reply 1033-4. PubMed ID: 20536437
    [No Abstract]   [Full Text] [Related]  

  • 6. CA 125: Value or addiction?
    Goldman PA
    Cancer; 2010 Jun; 116(12):2854-5. PubMed ID: 20564391
    [No Abstract]   [Full Text] [Related]  

  • 7. NICE consults on first national guideline on ovarian cancer.
    Mayor S
    BMJ; 2010 Sep; 341():c5296. PubMed ID: 20870704
    [No Abstract]   [Full Text] [Related]  

  • 8. The National Institute for Health and Clinical Excellence (NICE) guidelines for early detection of ovarian cancer: the pivotal role of the clinical laboratory.
    Sturgeon CM; Duffy MJ; Walker G
    Ann Clin Biochem; 2011 Jul; 48(Pt 4):295-9. PubMed ID: 21746796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress report on ovarian cancer screening. Scientists are making headway in detecting ovarian cancer at an earlier stage.
    Harv Womens Health Watch; 2010 Apr; 17(8):1-3. PubMed ID: 20506601
    [No Abstract]   [Full Text] [Related]  

  • 10. USPSTF says no screening for ovarian cancer in new guidelines.
    Oncology (Williston Park); 2012 Oct; 26(10):896, 928. PubMed ID: 23175994
    [No Abstract]   [Full Text] [Related]  

  • 11. Ovarian cancer screening and peritoneal carcinomatosis: standards, 'omics' and miRNAs for personalized management.
    Spiliotis J; Halkia E; Roukos DH
    Expert Rev Mol Diagn; 2011 Jun; 11(5):465-7. PubMed ID: 21707454
    [No Abstract]   [Full Text] [Related]  

  • 12. Introducing the MUC16 gene: implications for prevention and early detection in epithelial ovarian cancer.
    McLemore MR; Aouizerat B
    Biol Res Nurs; 2005 Apr; 6(4):262-7. PubMed ID: 15788735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of serum biomarkers for detection of early-stage ovarian cancer.
    Nosov V; Su F; Amneus M; Birrer M; Robins T; Kotlerman J; Reddy S; Farias-Eisner R
    Am J Obstet Gynecol; 2009 Jun; 200(6):639.e1-5. PubMed ID: 19285648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future of cancer screening.
    Collins LG; Wynn DT; Barash JH
    Prim Care; 2009 Sep; 36(3):623-39. PubMed ID: 19616158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalizing ovarian cancer screening.
    Goozner M
    J Natl Cancer Inst; 2010 Aug; 102(15):1112-3. PubMed ID: 20668268
    [No Abstract]   [Full Text] [Related]  

  • 16. A comprehensive look at the early detection of ovarian cancer.
    O'Rourke J; Mahon SM
    Clin J Oncol Nurs; 2003; 7(1):41-7. PubMed ID: 12629933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Screening for ovarian cancer].
    Nau JY
    Rev Med Suisse; 2012 Sep; 8(355):1842-3. PubMed ID: 23097870
    [No Abstract]   [Full Text] [Related]  

  • 18. Significance of a single CA 125 assay combined with ultrasound in the early detection of ovarian and endometrial cancer.
    Vuento MH; Stenman UH; Pirhonen JP; Mäkinen JI; Laippala PJ; Salmi TA
    Gynecol Oncol; 1997 Jan; 64(1):141-6. PubMed ID: 8995563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A step forward for two-step screening for ovarian cancer.
    Hensley ML
    J Clin Oncol; 2010 May; 28(13):2128-30. PubMed ID: 20368556
    [No Abstract]   [Full Text] [Related]  

  • 20. CA-125 monitoring in ovarian cancer: patient survey responses to the results of the MRC/EORTC CA-125 Surveillance Trial.
    Markman M; Petersen J; Belland A; Burg K
    Oncology; 2010; 78(1):1-2. PubMed ID: 20215782
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.